Results 221 to 230 of about 160,288 (338)

von Willebrand disease biology [PDF]

Haemophilia, 2012
Blomback, M., Eikenboom, J., Lane, D., Denis, C., Lillicrap, D.   +4 more
openaire   +4 more sources

Biomarkers of Endothelial Damage and Disease Severity in COVID-19 Patients. [PDF]

Curr Issues Mol Biol
Tsiatsiou P, Pilalas D, Tsaireli V, Lanta A, Meletis G, Kassomenaki A, Tza E, Tampakas L, Gkeka H, Papaioannou M, Protonotariou E, Skoura L.   +11 more
europepmc   +1 more source

How I treat patients with von Willebrand disease [PDF]

, 2001
Pier Mannuccio Mannucci
openalex   +1 more source

Willebrand factor in von Willebrand's disease. [PDF]

BMJ, 1975
F E Boulton, M J Lloyd
openaire   +3 more sources

Bleeding Complications in JAK2‐Variant Essential Thrombocythemia: A Revisit in 2025

eJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterised by sustained thrombocytosis. Paradoxically, bleeding complications remain an under‐recognised clinical challenge. Compared with CALR‐mutated patients, those harbouring the JAK2‐V617F variant appear more prone to haemorrhage.
Gerard Gurumurthy, Samantha Gurumurthy, Tim C. P. Somervaille, Anna Falanga, Jecko Thachil   +4 more
wiley   +1 more source

2025 ASH ISTH NBDF WFH monitoring report on the 2021 clinical guidelines on the diagnosis and management of von Willebrand disease. [PDF]

Blood Adv
James PD, Flood VH, Connell NT.
europepmc   +1 more source

Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins [PDF]

, 2001
Imre Bodó, Akira Katsumi, Elodee A. Tuley, Jeroen Eikenboom, Zhengyu Dong, J. Evan Sadler   +5 more
openalex   +1 more source

Post‐Diagnosis Hemorrhagic Events Are Strongly Associated With Poor Survival in Patients With Essential Thrombocythemia

eJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT Objectives The present study investigated the effects of thrombosis, hemorrhagic events, disease progression, and secondary malignancies on patient survival after the diagnosis of essential thrombocythemia (ET). Methods We analyzed data from 1152 patients enrolled in the JSH‐MPN‐18 study using time‐dependent Cox regression and multistate ...
Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, Mika Nakamae, Fumihiko Kimura, Michiaki Koike, Keita Kirito, Hideho Wada, Kensuke Usuki, Takayuki Tanaka, Takehiko Mori, Satoshi Wakita, Toshiki I. Saito, Akiko Kada, Akiko M. Saito, Kazuya Shimoda, Yuka Sugimoto, Toshiro Kurokawa, Akihiro Tomita, Yoko Edahiro, Hitoshi Kiyoi, Koichi Akashi, Itaru Matsumura, Katsuto Takenaka, Norio Komatsu   +24 more
wiley   +1 more source

Endothelial function and vascular events in patients with limited cutaneous systemic sclerosis (EFVELSS): a prospective observational study. [PDF]

Rheumatol Int
Jud P, Douschan P, Sassmann T, Silbernagel G, Gütl K, Raggam RB, Rief P, Schweiger L, John N, Seinost G, Foris V, Kovacs G, Gary T, Nemecz V, Meinitzer A, Strohmaier H, Odler B, Moazedi-Fürst F, Brodmann M, Hafner F.   +19 more
europepmc   +1 more source

Force-induced on-rate switching and modulation by mutations in gain-of-function von Willebrand diseases. [PDF]

Proc Natl Acad Sci U S A, 2015
Kim J, Hudson NE, Springer TA.
europepmc   +1 more source